pepidh1m
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2015 (NCT02193347)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Isocitrate dehydrogenase [NADP] cytoplasmicImmunity, active
IDH1 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pepidh1m
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05609994 | Phase 1 | Jan 31, 2023 | Duke University, Servier |
| NCT02193347 | Phase 1 | Dec 1, 2015 | Duke University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Duke University | Academic/Hospital | 2 | 2 | 1 | 2015 |
| Servier | For profit | 1 | 0 | 1 | 2023 |
2 organizations
Page 1 / 1